DataMEDS AI, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
2.84M
on 2026-06-30, from 1.02M on 2024-12-31 10-Q ↗
Earlier counts are adjusted for the 1-for-50 reverse split; each bar's tip shows the count as filed.
a raise that quarter, at its price
None
No at-the-market programme on file in the last 30 months.
Warrants
22K
Warrants of every class as tagged in the XBRL facts on 2026-01-20, exercise price $20.50. Adjusted for the 1-for-50 reverse split. 10-Q ↗
Cash
0.7 quarters
$2.5M on 2026-06-30 ÷ $3.4M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2025-09-25 | Public offering with warrants at $0.70 | 7,142,862 | $0.70 | $5.0M | 424B4 ↗ |
| 2025-02-21 | Public offering | not read | $4.50 | $4.0M | 424B4 ↗ |
Also on file: a 1-for-50 reverse split, 2025-05-26 8-K ↗ · $15.0M promissory notes, 2025-07-24 8-K ↗ · $21.1M convertible notes, 2026-05-27 8-K ↗